Literature DB >> 11325071

Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells.

H Tsuchida1, G Imai, Y Shima, T Satoh, S Owada.   

Abstract

Obesity-related non-insulin dependent diabetes mellitus (NIDDM) is frequently accompanied by hypertension. The present study was designed to clarify this mechanism. We first determined the blood pressure in male Wistar fatty rats (WFR), one of the NIDDM model rats, and in Wistar lean rats (WLR) as the control, with a normal (0.7% NaCl) or high (7% NaCl) salt diet. We observed no difference in systolic and mean blood pressures between WFR and WLR. WFR, however, became extremely hypertensive as a result of ingesting the high salt diet. We next investigated the mechanism for sodium sensitivity in WFR. Although the urinary excretion of dopamine (DA), a potent natriuretic factor, which reflects the ability for renal DA production, was preserved in WFR, the sodium balance with the high salt diet was positive. Moreover, Na-K-ATPase activity in isolated proximal convoluted tubules (PCT) from WFR with a normal salt diet was significantly (p<0.05) higher than that from WLR. A high salt load produced a significant (p<0.05) decrease in Na-K-ATPase activity in WLR but not in WFR. Similarly, Na-K-ATPase activity in WLR with a normal salt diet was significantly (p<0.05) inhibited by DA (10(-5) M), but this was not true in WFR. Furthermore, urinary excretion of norepinephrine in WFR with a high salt diet was the highest among all the groups. These results indicate that WFR tend to develop salt-sensitive hypertension that could be caused by the excessive sodium retention occurring as the results of a defective dopaminergic system in the kidney that fails to inhibit Na-K-ATPase activity. Augmentation of the renal sympathetic nervous system may play some role in this setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325071     DOI: 10.1291/hypres.24.127

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

Review 1.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

2.  Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats.

Authors:  Jiajie Luan; Weiping Li; Jia Han; Wen Zhang; Huiling Gong; Rong Ma
Journal:  J Pharmacol Sci       Date:  2012-05-22       Impact factor: 3.337

Review 3.  The connection between GRKs and various signaling pathways involved in diabetic nephropathy.

Authors:  Feng-Ling Wang; Li-Qin Tang; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-02-21       Impact factor: 2.316

4.  D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.

Authors:  Chunyu Zeng; Yu Han; Hefei Huang; Changqing Yu; Hongmei Ren; Weibin Shi; Duofen He; Lan Huang; Chengming Yang; Xukai Wang; Lin Zhou; Pedro A Jose
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

5.  Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats.

Authors:  Jian Yang; Zhigang Cui; Duofen He; Hongmei Ren; Yu Han; Changqing Yu; Chunjiang Fu; Zheng Wang; Chengming Yang; Xukai Wang; Lin Zhou; Laureano D Asico; Van Anthony M Villar; Ulrich Hopfer; Mantian Mi; Chunyu Zeng; Pedro A Jose
Journal:  Am J Hypertens       Date:  2009-04-16       Impact factor: 2.689

6.  Inhibition of D4 Dopamine Receptors on Insulin Receptor Expression and Effect in Renal Proximal Tubule Cells.

Authors:  Ye Zhang; Hongmei Ren; Xi Lu; Duofen He; Yu Han; Hongyong Wang; Chunyu Zeng; Weibin Shi
Journal:  J Am Heart Assoc       Date:  2016-04-22       Impact factor: 5.501

7.  Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.

Authors:  N L Rukavina Mikusic; N M Kouyoumdzian; E Rouvier; M M Gironacci; J E Toblli; B E Fernández; M R Choi
Journal:  Scientifica (Cairo)       Date:  2016-08-22

8.  Dopamine D₄ receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression.

Authors:  Changqing Yu; Zhen Wang; Yu Han; Yukai Liu; Wei Eric Wang; Caiyu Chen; Hongyong Wang; Pedro A Jose; Chunyu Zeng
Journal:  Cardiovasc Diabetol       Date:  2014-06-02       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.